↓ Skip to main content

Designing Trials of Disease Modifying Agents for Early and Preclinical Alzheimer’s Disease Intervention: What Evidence is Meaningful to Patients, Providers, and Payers?

Overview of attention for article published in The Journal of Prevention of Alzheimer's Disease, October 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

news
1 news outlet
twitter
10 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
50 Mendeley